Bevacızumab ELISA (mAb-based)

Enzyme immunoassay for the specific and quantitative determination of free Bevacizumab (Avastin) in serum and plasma.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Bevacizumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies, even with its 5 pointmutation Fab counterpart (Ranibizumab) is excluded.

Reference: IG-AB104

Barcode: 8682754930134

Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses.  It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Quality Control Certificates

Avastin® is a trademark of Genentech Inc./Roche.

Required Volume (µL)  10
Incubation Time (min)  100
Sample  Serum or Plasma
Package Size 96 Tests
Standard Range (µg/mL, 1000x)  0-200
Detection Limit (ng/mL) 5
Spike Recovery (%)  >95%
Shelf Life (years) 2